[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@Bio_Scout](/creator/twitter/Bio_Scout)
"$CLSD $RGNX @clearsidebio @REGENXBIO Late Breaking Abstract for the AAO conference Oct. 17-20th Suprachoroidal Surabgene Lomparvovec (Sura-vec ABBV-RGX-314): First Time 2-Year Results in Non-Proliferative Diabetic Retinopathy Dr. Wykoff MD PhD"  
[X Link](https://x.com/Bio_Scout/status/1961450257314623807) [@Bio_Scout](/creator/x/Bio_Scout) 2025-08-29T15:25Z XXX followers, XXX engagements


"$RGNX @REGENXBIO Dr. Khanani patient is 5+ years going strong on Regenxbio gene therapy: "My journey with sura-vec (formerly RGX-314) began during the Phase 1/2 trial where my enrolled patient remains injection-free to this day following a single dose.""  
[X Link](https://x.com/Bio_Scout/status/1975944891441279052) [@Bio_Scout](/creator/x/Bio_Scout) 2025-10-08T15:22Z XXX followers, XXX engagements


"$RGNX @REGENXBIO @AAO2025 $ABBV $CLSD @clearsidebio LATE BREAKING ABSTRACT AT AAO NEXT WEEK for RGNX: Suprachoroidal Surabgene Lomparvovec (Sura-vec ABBV-RGX-314): First Time 2-Year Results in Non-Proliferative Diabetic Retinopathy Charles C Wykoff MD"  
[X Link](https://x.com/Bio_Scout/status/1975966187445256671) [@Bio_Scout](/creator/x/Bio_Scout) 2025-10-08T16:47Z XXX followers, XXX engagements